Expression of ALDP Is Altered in X-linked Adrenoleukodystrophy
β Scribed by Watkins, P. A. (author);Gould, S. J. (author);Smith, M. A. (author);Braiterman, L. T. (author);Wei, H. M. (author);Kok, F. (author);Moser, B. (author);Moser, H. W. (author);Smith, K. D. (author)
- Book ID
- 111392313
- Publisher
- Blackwell Publishing Inc.
- Year
- 1996
- Tongue
- English
- Weight
- 102 KB
- Volume
- 804
- Category
- Article
- ISSN
- 0890-6564
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder caused by an impairment in peroxisomal β€-oxidation of very long straight-chain fatty acids (VLCFAs). Six clinical phenotypes have been delineated: childhood cerebral (CCALD), adolescent cerebral (AdolCALD), adult cerebral (ACAL
X-linked adrenoleukodystrophy (X-ALD) is due to an impairment in the peroxisomal -oxidation of very long straight chain fatty acids (VLCFAs) and the gene involved encodes a 75 kD protein (ALDP). Prenatal diagnosis is usually made by measurement of VLCFAs in cultured amniotic fluid cells (CAF) and ch